Bivalent BNT162b2mRNA original/Omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared to the monovalent COVID-19 booster https://www.medrxiv.org/content/10.1101/2022.11.07.22281982
Bivalent BNT162b2mRNA original/Omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared to the monovalent COVID-19 booster https://www.medrxiv.org/content/10.1101/2022.11.07.22281982